DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025

BROSSARD, Quebec, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it intends to extend the exercise period of an aggregate of 1,125,000 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on May 9, 2024 and set to expire on November 9, 2025.